-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Post-Traumatic Stress Disorder (PTSD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Post-Traumatic Stress Disorder (PTSD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Post-Traumatic Stress Disorder (PTSD) Drug Details: Brexanolone (Zulresso)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Alcohol Dependence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Alcohol Dependence report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Alcohol Dependence Drug Details: Brexanolone (Zulresso) is a mixture of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Tinnitus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Tinnitus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Tinnitus Drug Details: Brexanolone (Zulresso) is a mixture of allopregnanolone and...
-
Product Insights
Net Present Value Model: Zulresso
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Zulresso Drug Details Brexanolone (Zulresso) is...
-
Product Insights
LAigle
LAigle is a 360MW hydro power project located in Auvergne-Rhone-Alpes, France. It was developed by SGE Societe Generale d'Entreprises. The project is currently active. The project started its commercial operations in 1945. The project is owned by Electricite de France SA. LAigle profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific...